Global Metabolism Assays Market Size To Exceed USD 2.68 Billion By 2033 |CAGR of 7.10%
Category: HealthcareGlobal Metabolism Assays Market Size To Exceed USD 2.68 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Metabolism Assays Market Size is to grow from USD 1.35 Billion in 2023 to USD 2.68 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 7.10% during the projected period.
Get more details on this report -
Browse key industry insights spread across 200 pages with 110 Market data tables and figures & charts from the report on the "Global Metabolism assays Market Size, Share, and COVID-19 Impact Analysis, By Technology (Colorimetry, Spectrometry, and Fluorimetry), By Product Type (Kits, Reagents & Consumables, Instruments & Accessories, and Software & Services), By Application (Diabetes, Obesity, Cancer, and Others), By End-Use (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biopharmaceutical Companies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here : https://www.sphericalinsights.com/reports/metabolism-assays-market
Metabolism assays are the analytical methods that quantitatively determine the activity of metabolites or cellular processes, providing valuable insights into the metabolic reactions and the mechanisms of action of biomolecules such as carbohydrates and proteins. It is used to identify metabolic stability in chemical structures in connection with hepatic metabolism and evaluate the rate of drug clearance using liver hepatocytes or microsomes. Pharmacokinetic and pharmacodynamics properties of drugs, aiding in metabolic characterization of drug candidates. The evaluation of several metabolic parameters involved in the pathophysiology of the disease is made easier by metabolic assays. The development of personalized medicine and the incorporation of artificial intelligence and machine learning in metabolic research are poised to offer lucrative market opportunities for metabolism assays. The increasing prevalence of chronic diseases such as obesity, diabetes, and other mitochondrial disorders surges the need for deeper insights and breakthrough treatments for patients are driving the global metabolism assays market. The growing R&D related to metabolic disorders for novel drug discovery and development and the integration of innovative technologies like high throughput screening and bioinformatics are significantly driving the market. Further, the demand for in-depth metabolic profiling in the field of drug characterization is bolstering the market demand for metabolism assays. On the contrary, the high cost and limited budget facilities in research lab and healthcare sectors are restraining the global metabolism assays market.
The colorimetry segment is anticipated to hold the largest market share through the forecast period.
Based on the technology, the global metabolism assays market is segmented into colorimetry, spectrometry, and fluorimetry. Among these, the colorimetry segment is anticipated to hold the largest market share through the forecast period. Due to affordability and widespread adoption of colorimetry assay, it is versatile enough to be used in metabolic research. The ongoing advancements such as the development of novel substrates, enzyme-linked reactions, and detection methods are responsible for driving the market.
The kits, reagents & consumables segment dominates the market with the largest revenue share in 2023.
Based on product type, the global metabolism assays market is segmented into kits, reagents & consumables, instruments & accessories, and software & services. Among these, the kits, reagents & consumables segment dominates the market with the largest revenue share in 2023. Researchers can perform a variety of metabolic tests with the use of kits, reagents, and consumables, offering ready-to-use components with precision, quick reaction times, cost-effectiveness, and ease of use when using established procedures. Researchers examine enzymatic activity, glucose metabolism, lipid metabolism, and other metabolic processes using metabolism assays.
The diabetes segment dominated the global metabolism assays market over the forecast period.
Based on the application, the global metabolism assays market is segmented into diabetes, obesity, cancer, and others. Among these, the diabetes segment dominated the global metabolism assays market over the forecast period. Measurements of insulin sensitivity, glucose metabolism, and pancreatic beta-cell function can be performed with it, providing important insights into the genesis and course of the condition. The need for metabolism assays for diabetic research and clinical usage is growing due to the increasing prevalence of diabetes.
The hospital segment is expected to hold the largest market share during the forecast period.
Based on the end-use, the global metabolism assays market is segmented into hospitals, diagnostic laboratories, pharmaceutical & biopharmaceutical companies, and others. Among these, the hospital segment is expected to hold the largest market share during the forecast period. Metabolism assay is performed in hospitals to recognize and track metabolic conditions for diagnostic purposes, such as diabetes, lipid problems, and metabolic syndrome. Healthcare providers can tailor treatment programs with the use of metabolism testing. The rising demand for precision medicine and evidence-based care is bolstering the market demand in the hospital segment.
North America dominates the market with the largest market share over the forecast period.
Get more details on this report -
North America dominates the market with the largest market share over the forecast period. The presence of advanced and well-established healthcare infrastructure is significantly boosting the metabolism assays market. The increasing prevalence of chronic diseases in the region, government initiatives and technological advancements are contributing to market growth for metabolism assays. The growing cases of metabolic disorders in the region are anticipated to surge the market demand. Furthermore, the rise in awareness about metabolic disorders surges the demand for advanced diagnostic and treatment modalities which in turn drives the market demand in the region. The presence of hospitals, diagnostic and research institutes for the development of novel precision medicine, and evidence-based clinical treatment are significantly driving the market in the region.
Asia-Pacific region is expected to grow the fastest during the forecast period. The increasing awareness about metabolic disorders and their treatment with the growing prevalence of chronic diseases such as diabetes, cardiovascular disorder, and obesity surges the market demand for metabolism assays. The presence of well-established pharmaceutical and biotechnology organizations is propelling the market for metabolic assays. Further, rapid urbanization and lifestyle changes such as sedentary lifestyles, unhealthy diets, and obesity which are responsible for the growing prevalence of metabolic disorders are driving the market demand in the region.
Major vendors in the global metabolism assays market are Merck KGaA, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Abcam Plc., Promega Corporation, Bio-Rad Laboratories, RayBiotech Life, Inc., BMG Labtech GmbH, Kaneka Eurogentic S.A, Becton, Dickinson and Company, PerkinElmer Inc., Enzo Biochem, Inc., Promega Corporation, Sartorius AG, and Other Key Players.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In September 2023, Agilent Technologies Inc. signed a MoU (Memorandum of Understanding) with the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS), to develop cell and gene therapy advancement over the next three years. The new partnership sets out to install and operate Agilent’s xCELLigence real-time cell analyzer, Seahorse XF technology, and other cell analysis portfolio. The partnership also enables early access to Agilent’s new cell analysis platform which may be fundamental in developing cellular therapies for marketing authorization.
- In March 2022, Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announced the continuation of their collaboration to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterization of complex therapeutic proteins.
- In August 2021, Abcam plc, a global leader in the supply of life science research tools, announced that it has entered into a definitive agreement to acquire BioVision, Inc., a wholly owned subsidiary of Boai NKY Medical Holdings Ltd. (“NKY”), for $340 million. It is expected to bring greater control over the innovation and distribution of BioVision’s product portfolio and create value through portfolio expansion and leveraging Abcam’s global channels to market.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global metabolism assays market based on the below-mentioned segments:
Global Metabolism Assays Market, Technology Analysis
- Colorimetry
- Spectrometry
- Fluorimetry
Global Metabolism Assays Market, Product Type Analysis
- Kits, Reagents & Consumables
- Instruments & Accessories
- Software & Services
Global Metabolism Assays Market, Application Analysis
- Diabetes
- Obesity
- Cancer
- Others
Global Metabolism Assays Market, End-Use Analysis
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biopharmaceutical Companies
- Others
Global Metabolism Assays Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?